We are currently inviting applications for six Civil Society & Community Representatives to advocate the viewpoints and needs of NGOs and Communities within the ACT-Accelerator Therapeutics pillar supported by a constituency of NGOs and Community organisations. This process is coordinated by the Civil Society delegations to the Boards of Unitaid and Global Fund.
Please note the closing date for applications is: 28 June 2020.
The ACT-Accelerator (ACT-A) is designed to accelerate the development, production and equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines. The overarching coordination for ACT-Accelerator is the Facilitation Group, intended to oversee progress from the three main pillars:
- Vaccines (co-convenors: CEPI & Gavi)
- Therapeutics (co-convenors: Wellcome Trust & Unitaid)
- Diagnostics (co-convenors: FIND & Global Fund)
Within the therapeutics pillar there are 4 workstreams:
- Rapid evidence assessment of candidates (identify priority compounds or repurposed medicines to test for efficacy against COVID-19, and coordinate clinical trials portfolio and scientific direction)
- Market preparedness (facilitate market entry and supply at scale (inc. regulatory issues, intellectual property, manufacturing capacity, pricing)
- Adequate deployment in all countries (ensure procurement, equitable distribution and delivery at scale and in all settings)
- Costing/ financing (cross-cutting) (identify resource needs for successful delivery of partnership work including the preparation of investment cases)
Role of Civil Society & Community Representatives
The Civil Society & Communities Representatives will support the core activities of workstreams 1-3 and actively:
- Seek input from their constituents (NGOs and Communities) on decisions, including through consultations and the constituency mailing list
- Provide feedback on their activities and positions taken to their constituents through teleconferences and the mailing list
- Work together as a team to ensure that relevant information is shared across workstreams and to develop strategies that can be implemented collectively as the therapeutics pillar evolves.
The full terms of reference can be found: Civil Society & Community Representation (ACT-A Therapeutics Pillar) Terms of Reference
And the application form: Civil Society & Community Representation (ACT-A Therapeutics Pillar) Application Form
If you have any questions, please email email@example.com